We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » TAP, Novartis Sign Agreement to Develop OTC Prevacid
TAP, Novartis Sign Agreement to Develop OTC Prevacid
December 21, 2005
TAP Pharmaceutical has licensed the rights to its blockbuster heartburn drug Prevacid to Novartis, which will develop and market an OTC version of the drug when it goes off patent in 2009.